Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The Pentagon Copying Test and the Clock Drawing Test as Prognostic Markers in Dementia with Lewy Bodies.

Vergouw LJM, Salomé M, Kerklaan AG, Kies C, Roks G, van den Berg E, de Jong FJ.

Dement Geriatr Cogn Disord. 2018;45(5-6):308-317. doi: 10.1159/000490045. Epub 2018 Jul 11.

2.

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.

Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, IJpma AS, van IJcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V; International Parkinsonism Genetics Network.

Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.

PMID:
29887161
3.

Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.

Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ.

Neuropathol Appl Neurobiol. 2018 May 24. doi: 10.1111/nan.12501. [Epub ahead of print]

PMID:
29797340
4.

A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test-retest reliability and feasibility.

Jutten RJ, Harrison J, Lee Meeuw Kjoe PR, Opmeer EM, Schoonenboom NSM, de Jong FJ, Ritchie CW, Scheltens P, Sikkes SAM.

Alzheimers Dement (Amst). 2017 Dec 27;10:153-160. doi: 10.1016/j.dadm.2017.12.002. eCollection 2018.

5.

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.

Meeter LHH, Vijverberg EG, Del Campo M, Rozemuller AJM, Donker Kaat L, de Jong FJ, van der Flier WM, Teunissen CE, van Swieten JC, Pijnenburg YAL.

Neurology. 2018 Apr 3;90(14):e1231-e1239. doi: 10.1212/WNL.0000000000005261. Epub 2018 Mar 7.

6.

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study.

Jutten RJ, Harrison J, de Jong FJ, Aleman A, Ritchie CW, Scheltens P, Sikkes SAM.

Alzheimers Dement (N Y). 2017 Feb 9;3(1):130-138. doi: 10.1016/j.trci.2017.01.004. eCollection 2017 Jan.

7.

An update on the genetics of dementia with Lewy bodies.

Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ.

Parkinsonism Relat Disord. 2017 Oct;43:1-8. doi: 10.1016/j.parkreldis.2017.07.009. Epub 2017 Jul 13. Review.

PMID:
28734699
8.

Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.

Kramberger MG, Auestad B, Garcia-Ptacek S, Abdelnour C, Olmo JG, Walker Z, Lemstra AW, Londos E, Blanc F, Bonanni L, McKeith I, Winblad B, de Jong FJ, Nobili F, Stefanova E, Petrova M, Falup-Pecurariu C, Rektorova I, Bostantjopoulou S, Biundo R, Weintraub D, Aarsland D; E-DLB.

J Alzheimers Dis. 2017;57(3):787-795. doi: 10.3233/JAD-161109.

9.

Functional connectivity and microstructural white matter changes in phenocopy frontotemporal dementia.

Meijboom R, Steketee RM, de Koning I, Osse RJ, Jiskoot LC, de Jong FJ, van der Lugt A, van Swieten JC, Smits M.

Eur Radiol. 2017 Apr;27(4):1352-1360. doi: 10.1007/s00330-016-4490-4. Epub 2016 Jul 19.

10.

Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum.

Steketee RM, Meijboom R, Bron EE, Osse RJ, de Koning I, Jiskoot LC, Klein S, de Jong FJ, van der Lugt A, van Swieten JC, Smits M.

Neuroimage Clin. 2016 Apr 10;11:595-605. doi: 10.1016/j.nicl.2016.03.019. eCollection 2016.

11.

Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.

Steketee RM, Bron EE, Meijboom R, Houston GC, Klein S, Mutsaerts HJ, Mendez Orellana CP, de Jong FJ, van Swieten JC, van der Lugt A, Smits M.

Eur Radiol. 2016 Jan;26(1):244-53. doi: 10.1007/s00330-015-3789-x. Epub 2015 May 31.

12.

Apnea and dysphagia as the sole features of an α-synucleinopathy.

Gilhuis HJ, Panwar A, Van Duinen SG, De Jong FJ.

Neurology. 2014 Nov 18;83(21):1988-9. doi: 10.1212/WNL.0000000000000998. Epub 2014 Oct 22. No abstract available.

PMID:
25339214
13.

Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °C or above.

de Ridder IR, de Jong FJ, den Hertog HM, Lingsma HF, van Gemert HM, Schreuder AH, Ruitenberg A, Maasland EL, Saxena R, Oomes P, van Tuijl J, Koudstaal PJ, Kappelle LJ, Algra A, van der Worp HB, Dippel DW.

Int J Stroke. 2015 Apr;10(3):457-62. doi: 10.1111/ijs.12053. Epub 2013 May 22.

PMID:
23692587
14.

Retinal vascular calibers associate differentially with cerebral gray matter and white matter atrophy.

Ikram MK, de Jong FJ, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Klaver CC, Ikram MA.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):351-5. doi: 10.1097/WAD.0b013e31829344ed.

PMID:
23632264
15.

A high physical symptom count reduces the effectiveness of treatment for depression, independently of chronic medical conditions.

Huijbregts KM, de Jong FJ, van Marwijk HW, Beekman AT, Adèr HJ, van der Feltz-Cornelis CM.

J Psychosom Res. 2013 Mar;74(3):179-85. doi: 10.1016/j.jpsychores.2013.01.004. Epub 2013 Jan 30.

PMID:
23438706
16.

A target-driven collaborative care model for Major Depressive Disorder is effective in primary care in the Netherlands. A randomized clinical trial from the depression initiative.

Huijbregts KM, de Jong FJ, van Marwijk HW, Beekman AT, Adèr HJ, Hakkaart-van Roijen L, Unützer J, van der Feltz-Cornelis CM.

J Affect Disord. 2013 Apr 25;146(3):328-37. doi: 10.1016/j.jad.2012.09.015. Epub 2012 Oct 13.

PMID:
23068021
17.

Progressive ataxia and palatal tremor--two cases with an unusual clinical presentation and course.

de Jong FJ, Boon AJ.

Parkinsonism Relat Disord. 2012 Aug;18(7):904-5. doi: 10.1016/j.parkreldis.2012.04.002. Epub 2012 Apr 28. No abstract available.

PMID:
22542397
18.

Retinal vascular caliber and risk of dementia: the Rotterdam study.

de Jong FJ, Schrijvers EM, Ikram MK, Koudstaal PJ, de Jong PT, Hofman A, Vingerling JR, Breteler MM.

Neurology. 2011 Mar 1;76(9):816-21. doi: 10.1212/WNL.0b013e31820e7baa. Epub 2011 Feb 2.

19.

Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial.

van der Feltz-Cornelis CM, Hoedeman R, de Jong FJ, Meeuwissen JA, Drewes HW, van der Laan NC, Adèr HJ.

Neuropsychiatr Dis Treat. 2010 Sep 7;6:375-85.

20.

Adverse effects of multiple physical symptoms on the course of depressive and anxiety symptoms in primary care.

Huijbregts KM, van Marwijk HW, de Jong FJ, Schreuders B, Beekman AT, van der Feltz-Cornelis CM.

Psychother Psychosom. 2010;79(6):389-91. doi: 10.1159/000320899. Epub 2010 Sep 9. No abstract available.

PMID:
20829652
21.

Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review.

Huijbregts KM, van der Feltz-Cornelis CM, van Marwijk HW, de Jong FJ, van der Windt DA, Beekman AT.

J Psychosom Res. 2010 Jun;68(6):511-9. doi: 10.1016/j.jpsychores.2009.11.009. Epub 2010 Jan 21. Review.

PMID:
20488267
22.

Coma in thrombotic thrombocytopenic purpura.

de Jong FJ, Te Boekhorst PA, Dippel DW, Jacobs BC.

BMJ Case Rep. 2010 Nov 23;2010. pii: bcr0620103113. doi: 10.1136/bcr.06.2010.3113.

23.

The Depression Initiative. Description of a collaborative care model for depression and of the factors influencing its implementation in the primary care setting in the Netherlands.

de Jong FJ, van Steenbergen-Weijenburg KM, Huijbregts KM, Vlasveld MC, Van Marwijk HW, Beekman AT, van der Feltz-Cornelis CM.

Int J Integr Care. 2009 Jun 15;9:e81.

24.

Organic anion transporter 1B1: an important factor in hepatic thyroid hormone and estrogen transport and metabolism.

van der Deure WM, Friesema EC, de Jong FJ, de Rijke YB, de Jong FH, Uitterlinden AG, Breteler MM, Peeters RP, Visser TJ.

Endocrinology. 2008 Sep;149(9):4695-701. doi: 10.1210/en.2008-0169. Epub 2008 May 22.

PMID:
18499754
25.

Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease.

Ikram MA, van Oijen M, de Jong FJ, Kors JA, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM.

Stroke. 2008 May;39(5):1421-6. doi: 10.1161/STROKEAHA.107.501106. Epub 2008 Mar 6. Erratum in: Stroke. 2008 Sep;39(9): e148.

PMID:
18323497
26.

Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.

Knauff EA, Richardus R, Eijkemans MJ, Broekmans FJ, de Jong FJ, Fauser BC, Bosch AM.

Reprod Sci. 2007 Dec;14(8):780-5.

PMID:
18089596
27.

Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study.

de Jong FJ, Vernooij MW, Ikram MK, Ikram MA, Hofman A, Krestin GP, van der Lugt A, de Jong PT, Breteler MM.

Ophthalmology. 2008 May;115(5):887-92. Epub 2007 Dec 11.

PMID:
18067967
28.

Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study.

de Jong FJ, Masaki K, Chen H, Remaley AT, Breteler MM, Petrovitch H, White LR, Launer LJ.

Neurobiol Aging. 2009 Apr;30(4):600-6. Epub 2007 Sep 17.

29.

Complement factor h polymorphism, inflammatory mediators, and retinal vessel diameters: the rotterdam study.

de Jong FJ, Ikram MK, Despriet DD, Uitterlinden AG, Hofman A, Breteler MM, de Jong PT.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3014-8.

PMID:
17591866
30.

Retinal vessel diameters and the role of inflammation in cerebrovascular disease.

de Jong FJ, Ikram MK, Witteman JC, Hofman A, de Jong PT, Breteler MM.

Ann Neurol. 2007 May;61(5):491-5.

PMID:
17431876
31.

Subjective memory complaints, education, and risk of Alzheimer's disease.

van Oijen M, de Jong FJ, Hofman A, Koudstaal PJ, Breteler MM.

Alzheimers Dement. 2007 Apr;3(2):92-7. doi: 10.1016/j.jalz.2007.01.011. Epub 2007 Mar 23.

PMID:
19595922
32.

Atherosclerosis and risk for dementia.

van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM.

Ann Neurol. 2007 May;61(5):403-10.

PMID:
17328068
33.

Randomised controlled trial of a psychiatric consultation model for treatment of common mental disorder in the occupational health setting.

van der Feltz-Cornelis CM, Meeuwissen JA, de Jong FJ, Hoedeman R, Elfeddali I.

BMC Health Serv Res. 2007 Feb 27;7:29.

34.

Glucocorticoid receptor variant and risk of dementia and white matter lesions.

van Rossum EF, de Jong FJ, Koper JW, Uitterlinden AG, Prins ND, van Dijk EJ, Koudstaal PJ, Hofman A, de Jong FH, Lamberts SW, Breteler MM.

Neurobiol Aging. 2008 May;29(5):716-23. Epub 2006 Dec 20.

PMID:
17184882
35.

The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.

de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ, Breteler MM.

J Clin Endocrinol Metab. 2007 Feb;92(2):636-40. Epub 2006 Nov 14.

PMID:
17105838
36.

Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia.

Smit P, Dekker MJ, de Jong FJ, van den Beld AW, Koper JW, Pols HA, Brinkmann AO, de Jong FH, Breteler MM, Lamberts SW.

J Clin Endocrinol Metab. 2007 Jan;92(1):359-62. Epub 2006 Oct 24.

PMID:
17062770
37.

Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia.

van Oijen M, de Maat MP, Kardys I, de Jong FJ, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM.

Neurobiol Aging. 2007 Sep;28(9):1361-6. Epub 2006 Jul 18.

PMID:
16854501
38.

Retinal vessel diameters and risk of stroke: the Rotterdam Study.

Ikram MK, de Jong FJ, Bos MJ, Vingerling JR, Hofman A, Koudstaal PJ, de Jong PT, Breteler MM.

Neurology. 2006 May 9;66(9):1339-43.

PMID:
16682664
39.

Thyroid hormones, dementia, and atrophy of the medial temporal lobe.

de Jong FJ, den Heijer T, Visser TJ, de Rijke YB, Drexhage HA, Hofman A, Breteler MM.

J Clin Endocrinol Metab. 2006 Jul;91(7):2569-73. Epub 2006 Apr 24.

PMID:
16636121
40.

Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study.

van Oijen M, Arp PP, de Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, Breteler MM.

Neurosci Lett. 2006 Jul 10;402(1-2):113-7. Epub 2006 Apr 25.

PMID:
16635548
41.

Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study.

Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, De Jong PT.

Brain. 2006 Jan;129(Pt 1):182-8. Epub 2005 Nov 29.

PMID:
16317022
42.

Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study.

Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM, de Jong PT.

Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2129-34.

PMID:
15223786
43.

Improving service delivery: provider perspectives on building community-based systems of care.

Myrtle RC, Wilber KH, De Jong FJ.

J Health Hum Serv Adm. 1997 Fall;20(2):197-216.

PMID:
10177078
44.

Mammography use in older women with regular physicians: what are the predictors?

Mayer-Oakes SA, Atchison KA, Matthias RE, De Jong FJ, Lubben J, Schweitzer SO.

Am J Prev Med. 1996 Jan-Feb;12(1):44-50.

PMID:
8776294
45.

Screening for depression among a well elderly population.

Dorfman RA, Lubben JE, Mayer-Oakes A, Atchison K, Schweitzer SO, De Jong FJ, Matthias RE.

Soc Work. 1995 May;40(3):295-304.

PMID:
7761915
46.

Health promotion and disease prevention for older adults: opportunity for change or preaching to the converted?

Schweitzer SO, Atchison KA, Lubben JE, Mayer-Oakes SA, De Jong FJ, Matthias RE.

Am J Prev Med. 1994 Jul-Aug;10(4):223-9.

PMID:
7803065
47.

The relationship between dental utilization and preventive participation among a well-elderly sample.

Atchison KA, Mayer-Oakes SA, Schweitzer SO, Lubben JE, De Jong FJ, Matthias RE.

J Public Health Dent. 1993 Spring;53(2):88-95.

PMID:
8515416

Supplemental Content

Loading ...
Support Center